See Mechanism of Action of Select Antiretrovirals table.
Pharmacologic Profile
General Use
The goal of antiretroviral therapy in the management of HIV infection is to improve CD4 cell counts and ↓ viral load. If accomplished, this generally results in slowed progression of the disease, improved quality of life, and ↓ opportunistic infections. Perinatal use of agents also prevents transmission of the virus to the fetus. Postexposure and pre-exposure prophylaxis with certain antiretrovirals is also recommended.
General Action and Information
MECHANISM OF ACTION OF SELECT ANTIRETROVIRALS| DRUG | MECHANISM |
|---|---|
| Lamivudine, tenofovir alafenamide, and zidovudine | Nucleoside reverse transcriptase inhibitors (NRTIs) |
| Cabotegravir and dolutegravir | Integrase strand transfer inhibitors (INSTIs) |
| Darunavir and ritonavir | Protease inhibitors |
| Lencapavir | Capsid inhibitor |
| Rilpvirine | Non-nucleoside reverse transcriptase inhibitor (NNRTI) |
Contraindications
Hypersensitivity. Because of highly varying toxicities among agents, see individual monographs for more specific information.
Precautions
Many agents require modification for renal impairment. Protease inhibitors may cause hyperglycemia and hyperlipidemia and should be used cautiously in patients with diabetes and patients at increased risk for cardiovascular disease. Hemophiliacs may also be at risk of bleeding when taking protease inhibitors. See individual monographs for specific information.
Interactions
There are many significant and potentially serious drug-drug interactions among the antiretrovirals. Many of these interactions involve the cytochrome P450 system. See individual agents.
Nursing Implications
Assessment
Implementation
Patient/Family Teaching
Evaluation/Desired Outcomes